Warfarin Accelerates Medial Arterial Calcification in Humans

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Pharmacology

Background:

• Warfarin is a common anticoagulant used to prevent blood clots.
• Previous studies suggest a link between warfarin and medial arterial calcification (MAC).
• The specific impact of warfarin on MAC progression and the influence of other risk factors remain unclear.

Purpose of the Study:

• To investigate the magnitude and specificity of warfarin's effect on medial arterial calcification progression.
• To assess the role of renal function, diabetes, age, and duration of therapy in warfarin-associated MAC.

Main Methods:

• Serial mammograms were used to measure arterial calcification progression in women.
• Participants were categorized into groups: no anticoagulants, warfarin, or other anticoagulants.
• Progression was quantified as millimeters per breast per year and analyzed in relation to renal function and other risk factors.

Main Results:

• Warfarin users with normal renal function showed a 3.9-fold greater progression of arterial calcification compared to controls.
• Arterial calcification progression increased after starting warfarin and decreased after discontinuation.
• Progression was markedly accelerated in warfarin users with end-stage renal disease, but similar in those with chronic kidney disease or diabetes.

Conclusions:

• Warfarin significantly accelerates medial arterial calcification in humans.
• This acceleration is markedly augmented in patients with end-stage renal disease.
• The effect is specific to warfarin and not observed with other anticoagulants.